Related Experiment Videos

Potential of protein OprF of Pseudomonas in bivalent vaccines

R E Hancock1, R Wong

  • 1Department of Microbiology and Immunology, University of British Columbia, Vancouver.

Behring Institute Mitteilungen
|February 1, 1997
PubMed

Insights

Outer membrane protein OprF from Pseudomonas aeruginosa can be engineered in Escherichia coli to display foreign epitopes. This OprF-based carrier elicits epitope-specific antibodies, showing potential for vaccine development.

Area of Science:

  • Microbiology
  • Immunology
  • Biotechnology

Background:

  • Outer membrane protein OprF is a major component of Pseudomonas aeruginosa.
  • OprF possesses conserved surface epitopes that elicit protective antibodies.
  • Developing OprF as a carrier for foreign antigens is a strategy for novel vaccine development.

Purpose of the Study:

  • To engineer the OprF protein as a carrier for foreign epitopes.
  • To investigate the feasibility of expressing foreign epitopes on the surface of Escherichia coli using OprF.
  • To assess the antigenicity and immunogenicity of OprF displaying foreign epitopes.

Main Methods:

  • OprF gene was cloned and expressed in Escherichia coli.
  • Linker insertion mutagenesis was used to introduce PstI sites for foreign epitope insertion.
  • A model malarial epitope was inserted at various sites within OprF.
  • Immunization of mice with engineered OprF and analysis of antibody responses.

Main Results:

  • Nine insertion sites within OprF were identified that can express foreign epitopes on the E. coli surface.
  • Antigenicity of inserted epitopes was site-specific and influenced by surrounding amino acids.
  • The length of the inserted epitope affected its antigenicity.
  • Immunization with OprF-displayed epitopes induced epitope-specific antibodies.

Conclusions:

  • Pseudomonas aeruginosa outer membrane protein OprF can be genetically modified to serve as a carrier for foreign epitopes.
  • Engineered OprF expressed on E. coli surface demonstrates potential for displaying immunogenic epitopes.
  • OprF-based carriers show promise for developing new vaccines against infectious diseases.

Related Concept Videos